Literature DB >> 34743926

Colony stimulating factors in the nervous system.

Violeta Chitu1, Fabrizio Biundo2, E Richard Stanley3.   

Abstract

Although traditionally seen as regulators of hematopoiesis, colony-stimulating factors (CSFs) have emerged as important players in the nervous system, both in health and disease. This review summarizes the cellular sources, patterns of expression and physiological roles of the macrophage (CSF-1, IL-34), granulocyte-macrophage (GM-CSF) and granulocyte (G-CSF) colony stimulating factors within the nervous system, with a particular focus on their actions on microglia. CSF-1 and IL-34, via the CSF-1R, are required for the development, proliferation and maintenance of essentially all CNS microglia in a temporal and regional specific manner. In contrast, in steady state, GM-CSF and G-CSF are mainly involved in regulation of microglial function. The alterations in expression of these growth factors and their receptors, that have been reported in several neurological diseases, are described and the outcomes of their therapeutic targeting in mouse models and humans are discussed.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CSF-1; CSF-1R; G-CSF; GM-CSF; IL-34; Microglia

Mesh:

Substances:

Year:  2021        PMID: 34743926      PMCID: PMC8671346          DOI: 10.1016/j.smim.2021.101511

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  435 in total

1.  Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism: role of granulocyte macrophage colony-stimulating factor.

Authors:  Carmen Henze; Andreas Hartmann; Thomas Lescot; Etienne C Hirsch; Patrick P Michel
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

2.  Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains.

Authors:  G Guillemin; F D Boussin; R Le Grand; J Croitoru; H Coffigny; D Dormont
Journal:  Glia       Date:  1996-01       Impact factor: 7.452

3.  Granulocyte Colony Stimulating Factor Enhances Reward Learning through Potentiation of Mesolimbic Dopamine System Function.

Authors:  Munir Gunes Kutlu; Lillian J Brady; Emily G Peck; Rebecca S Hofford; Jordan T Yorgason; Cody A Siciliano; Drew D Kiraly; Erin S Calipari
Journal:  J Neurosci       Date:  2018-08-27       Impact factor: 6.167

Review 4.  Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis.

Authors:  Marian Simka
Journal:  Curr Neurovasc Res       Date:  2009-05       Impact factor: 1.990

Review 5.  Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature.

Authors:  Hakan Gümüş; Hüseyin Per; Sefer Kumandaş; Ali Yikilmaz
Journal:  Neurol Sci       Date:  2009-10-07       Impact factor: 3.307

6.  Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.

Authors:  Konrad Gabrusiewicz; Aleksandra Ellert-Miklaszewska; Maciej Lipko; Malgorzata Sielska; Marta Frankowska; Bozena Kaminska
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

7.  Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy.

Authors:  Liam Kempthorne; Hyejin Yoon; Charlotte Madore; Scott Smith; Zbigniew K Wszolek; Rosa Rademakers; Jungsu Kim; Oleg Butovsky; Dennis W Dickson
Journal:  Acta Neuropathol Commun       Date:  2020-05-19       Impact factor: 7.801

8.  Increased serum interleukin-34 levels as a novel diagnostic and prognostic biomarker in patients with acute ischemic stroke.

Authors:  Xiaoyu Huang; Fengzhan Li; Tingting Yang; Hao Li; Tan Liu; Yingying Wang; Minmin Xu; Lisha Yan; Yong Zhang; Yuzhong Wang; Linlin Fu; Deqin Geng
Journal:  J Neuroimmunol       Date:  2021-06-30       Impact factor: 3.478

9.  Targeting macrophage and microglia activation with colony stimulating factor 1 receptor inhibitor is an effective strategy to treat injury-triggered neuropathic pain.

Authors:  SeungHwan Lee; Xiang Qun Shi; Anni Fan; Brian West; Ji Zhang
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

10.  Unique and shared inflammatory profiles of human brain endothelia and pericytes.

Authors:  Leon C D Smyth; Justin Rustenhoven; Thomas I-H Park; Patrick Schweder; Deidre Jansson; Peter A Heppner; Simon J O'Carroll; Edward W Mee; Richard L M Faull; Maurice Curtis; Mike Dragunow
Journal:  J Neuroinflammation       Date:  2018-05-11       Impact factor: 8.322

View more
  3 in total

1.  Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.

Authors:  Shang-Yu Wang; Yu-Fang Lo; Han-Po Shih; Mao-Wang Ho; Chun-Fu Yeh; Jhan-Jie Peng; He-Ting Ting; Kuo-Hsi Lin; Wen-Chi Huang; Yi-Chun Chen; Yu-Hsin Chiu; Chien-Wei Hsu; Yu-Ting Tseng; Lih-Shinn Wang; Wei-Yi Lei; Chen-Yuan Lin; Yu Aoh; Chia-Huei Chou; Tsai-Yi Wu; Jing-Ya Ding; Chia-Chi Lo; You-Ning Lin; Kun-Hua Tu; Wei-Te Lei; Chen-Yen Kuo; Chih-Yu Chi; Cheng-Lung Ku
Journal:  J Clin Immunol       Date:  2022-08-10       Impact factor: 8.542

Review 2.  CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple.

Authors:  David A Hume; Lena Batoon; Anuj Sehgal; Sahar Keshvari; Katharine M Irvine
Journal:  Curr Osteoporos Rep       Date:  2022-10-05       Impact factor: 5.163

3.  Two Novel Intronic Mutations in the CSF1R Gene in Two Families With CSF1R-Microglial Encephalopathy.

Authors:  Jiwei Jiang; Wenyi Li; Xiaohong Wang; Zhongli Du; Jinlong Chen; Yaou Liu; Wei Li; Zhonghua Lu; Yanli Wang; Jun Xu
Journal:  Front Cell Dev Biol       Date:  2022-05-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.